+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Differential mechanisms for suppression of natural killer nk and lymphokine activated killer lak cell mediated cytolytic responses by lymphocytes isolated from breast cancer patients on chemotherapy and aids subjects



Differential mechanisms for suppression of natural killer nk and lymphokine activated killer lak cell mediated cytolytic responses by lymphocytes isolated from breast cancer patients on chemotherapy and aids subjects



Anticancer Research 10(5 Part B): 1428




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030934717

Download citation: RISBibTeXText


Related references

Adherent lymphokine-activated natural killer cells in normal and severe combined immunodeficiency mice: large granular lymphocytes with natural killer cell phenotype and high cytolytic activity. Natural Immunity and Cell Growth Regulation 8(2): 89-99, 1989

Natural killer and lymphokine-activated killer cell-mediated cytotoxicity in patients with oral cancer. Seminars in Surgical Oncology 5(5): 347-350, 1989

Natural killer cells, lymphokine-activated killer cells, and cytolytic T lymphocytes: compartmentalization of age-related changes in cytolytic lymphocytes?. Journal of Gerontology 49(3): B85-B92, 1994

Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer (philadelphia). 72(2): 491-501, 1993

IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes. Journal of Immunology 140(10): 3679-3685, 1988

Phenotypic and functional analysis at the clonal level of infiltrating T lymphocytes in papillary carcinoma of the thyroid: prevalence of cytolytic T cells with natural killer-like or lymphokine-activated killer activity. Journal of Clinical Endocrinology and Metabolism 69(4): 832-836, 1989

Natural killer and lymphokine-activated killer activities in stomach cancer patients with special emphasis on the effect of 5-fluorouracil, adriamycin and mitomycin-C chemotherapy. Japanese Journal of Clinical Oncology 20(1): 87-93, 1990

Natural killer cell immunodeficiency in siblings: defective killing in the absence of natural killer cytotoxic factor activity in natural killer and lymphokine-activated killer cytotoxicities. Pediatrics 85(3): 323-330, 1990

Induction of lymphokine-activated killer and natural killer cell activities from cryopreserved lymphocytes. Transfusion 28(6): 531-535, 1988

Natural killer and lymphokine activated killer cytotoxicity of human peripheral blood lymphocytes against nine human colon cancer cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 29: 395, 1988

An open-label, randomized trial of the effects of macrophage versus granulocyte colony-stimulating factor on natural killer cell activity, lymphokine activated killer cell activity, interleukin-2 production, and leukocyte count in patients after chemotherapy for ovarian cancer. Current Therapeutic Research. 58(10): 698-705, 1997

Correspondence re: John R. Yanelli et al., Enhancement of Human Lymphokine-activated Killer Cell Cytolysis and a Method for Increasing Lymphokine-activated Killer Cell Yields to Cancer Patients. Cancer Res., 48: 5696-5700, 1988. Cancer Research 49(15): 4369-4369, 1989

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. Journal of Experimental Medicine 157(3): 884-897, 1983

Enhancement of human lymphokine-activated killer cell cytolysis and a method for increasing lymphokine-activated killer cell yields to cancer patients. Cancer Research 48(20): 5696-5700, 1988

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. Journal of Experimental Medicine 155(6): 1823-1841, 1982